Improvement of gamete quality by stimulating and feeding the endogenous antioxidant system: mechanisms, clinical results, insights on gene-environment interactions and the role of diet

Maurizio Dattilo, Giuseppe D'Amato, Ettore Caroppo, Yves Ménézo, Maurizio Dattilo, Giuseppe D'Amato, Ettore Caroppo, Yves Ménézo

Abstract

Oxidative damage triggers extensive repair in gametes and thereafter in the zygote but it results in clinically relevant damage when affecting the maturation of the gametes chromatin, i.e. padlocking and epigenetic marking. It associates with defective DNA methylation and/or with oxidation of the methyl marks leading to derangement of gamete epigenetics, defects of chromatin condensation and aneuploidy. A proper feed to the one carbon cycle has the potential to stimulate the endogenous antioxidant defences, i.e. gluthatione synthesis, and to activate compensative homeostatic mechanisms restoring both the oxy-redox balance and DNA methylation, which are indeed strictly cross-regulated. This has been shown to produce measurable clinical improvements of male reproductive potential in pilot studies herein summarised. However, the effects of dietary habits and of supplementations are variable according to the individual genetic substrate, as genetic variants of several of the concerned enzymes occur with high frequency. Individual risk assessments and personalised interventions are still difficult to implement, in the meantime, a very varied diet may facilitate metabolic compensation in the majority of the cases. This review aims to report on the mechanisms of damage, on the opportunities to modulate the physiologic oxy-redox homeostasis by means of a varied diet or dietary supplements and on the open issues related to the genetic variability of the population.

Keywords: DNA methylation; Epigenesis; Oocyte; Oxidative stress; Sperm.

Conflict of interest statement

MD is R&D Director and shareholder at Parthenogen SAGL, a private company engaged in the development of dietary supplements. The other authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Epigenetic instability from oxidative damage. a The methylation of cytosine (filled circles) within CpG repeats to form methyl cytosine causes loss of affinity of the transcription factors for the promoter and silencing of the gene. b If the cytosines are not methylated (empty circles) due to lack of SAMe or if the methylation mark is lost due to de-methylation triggered by methyl cytosine oxidation, the gene is not anymore silenced and may undergo inappropriate expression. c If either the methyl cytosine or the guanosine of the CpG repeat are oxidised (small filled circles), the domain reverts from hydrophobic back to hydrophilic and the transcription factors recover the ability to bind and to express the gene in spite of the methylation of the CpG island. Both cases b and c lead to epigenetic instability
Fig. 2
Fig. 2
Connection between the one carbon cycle and the transsulfuration pathway (GSH synthesis). Upper panel The methyl group of methionine is activated by adenylation to form S-Adenosyl-Methionine (SAMe) that acts as the universal methyl donor for any acceptor including DNA: a molecule of homocysteine is formed. Homocysteine can be either re-methylated from folates or betaine or enter the transsulfuration pathway for the synthesis of glutathione (GSH). Lower panel Homocysteine is complexed with serine to form cystathionine and to feed the de-novo synthesis of GSH
Fig. 3
Fig. 3
Regulation of cystathionine-beta-synthase (CBS) activity. The enzyme is formed by a tetramer of CBS domains complexed with a heme functioning as a redox sensor. The oxidation of the heme group activates the enzyme. However, a significant activity funneling homocysteine into the trannssulfuration pathway will only occur if SAMe is available and binding to the carboxy-terminal end of the CBS domains. Thus, full efficiency of the transsulfuration pathways for GSH synthesis will only occur after the requirement for activated methyl groups (SAMe) for the one carbon cycle is satisfied
Fig. 4
Fig. 4
Schematic map of the possible genetic blockades to the 1CC and the GSH synthesis. All of the enzyme variants of concern have a high prevalence in the population and the chances for multiple defects are accordingly high. The final phenotype, i.e. the function of the carbon metabolism and of the antioxidant defenses, will depend on the variable combination of these genetic substrates with environmental factors including the diet and intercurrent diseases. MTHFR Methyl-Tetra-Hydro-Folate-Reductase, MTR Methionine Synthase, MTRR Methionine Synthase Reductase, BHMT Betaine Homocysteine Methyl Transferase, CBS Cistathionine Beta Synthase, CHDH Choline Dehydrogenase
Fig. 5
Fig. 5
Food folates compared to supplement folates. The folates found in food consist of a mixture of reduced folates, mainly 5-Methyl-Tetrahydrofolate as shown in the figure. They also come with a polyglutamate tail (not shown), further increasing the solubility, whose length varies according to the type of food. Dietary supplements and fortified foods usually contain the synthetic form folic acid that is better stable, cheaper and easier to manufacture. Folic acid requires enzymatic reduction by the enzyme MTHFR (see red circles) to become soluble and bioavailable to cell metabolism. Subjects with a deficient MTHFR activity may not be able to process loads of the synthetic form. It is also to be noted that the reduction of folic acid from supplements consumes proportional amounts of NADPH and may be further hampered by any oxidative stress causing imbalance of NADP toward the oxidised form NADP+

References

    1. Chatzianagnostou K, Del Turco S, Pingitore A, Sabatino L, Vassalle C. The mediterranean lifestyle as a non-pharmacological and natural antioxidant for healthy aging. Antioxidants (Basel) 2015;4(4):719–36. doi: 10.3390/antiox4040719.
    1. Lee SA. Gene-diet interaction on cancer risk in epidemiological studies. J Prev Med Public Health. 2009;42(6):360–70. doi: 10.3961/jpmph.2009.42.6.360.
    1. Daxinger L, Whitelaw E. Transgenerational epigenetic inheritance: more questions than answers. Genome Res. 2010;20(12):1623–8. doi: 10.1101/gr.106138.110.
    1. Ménézo Y, Dale B, Cohen M. DNA damage and repair in human oocytes and embryos: a review. Zygote. 2010;18(4):357–65. doi: 10.1017/S0967199410000286.
    1. Ioannou D, Miller D, Griffin DK, Tempest HG. Impact of sperm DNA chromatin in the clinic. J Assist Reprod Genet. 2016;33:157–66. doi: 10.1007/s10815-015-0624-x.
    1. Hammadeh ME, Hamad MF, Montenarh M, Fischer-Hammadeh C. Protamine contents and P1/P2 ratio in human spermatozoa from smokers and non-smokers. Hum Reprod. 2010;25(11):2708–20. doi: 10.1093/humrep/deq226.
    1. Li E, Zhang Y. DNA methylation in mammals. Cold Spring Harb Perspect Biol. 2014;6:a019133. doi: 10.1101/cshperspect.a019133.
    1. Rose NR, Klose RJ. Understanding the relationship between DNA methylation and histone lysine methylation. Biochim Biophys Acta. 1839;2014:1362–72.
    1. Ward S. Function of sperm chromatin structural elements in fertilization and development. Mol Hum Reprod. 2010;16(1):30–6. doi: 10.1093/molehr/gap080.
    1. Luciano AM, Franciosi F, Dieci C, Tessaro I, Terzaghi L, Modina SC, Lodde V. Large-scale chromatin structure and function changes during oogenesis: the interplay between oocyte and companion cumulus cells. Anim Reprod. 2014;11(3):141–9.
    1. Guo JU, Su Y, Zhong C, Ming G, Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell. 2011;145(3):423–34. doi: 10.1016/j.cell.2011.03.022.
    1. Donkena KV, Young CYF, Tindall DJ. Oxidative Stress and DNA Methylation in Prostate Cancer. Obst Gynecol Int. 2010;302051:14.
    1. Wu J, Basha R, Brock B, Cox DP, Cardozo-Pelaez F, McPherson CA, Harry J, Rice DC, Maloney B, Chen D, Lahiri DK, Zawia NH. Alzheimer’s disease (AD) like pathology in aged monkeys following infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J Neurosci. 2008;28(1):3–9. doi: 10.1523/JNEUROSCI.4405-07.2008.
    1. Chan RC, Severson AF, Meyer BJ. Condensin restructures chromosomes in preparation for meiotic divisions. J Cell Biol. 2004;167(4):613–25. doi: 10.1083/jcb.200408061.
    1. Zamudio N, Barau J, Teissandier A, Walter M, Borsos M, Servant N, Bourc’his D. DNA methylation restrains transposons from adopting a chromatin signature permissive for meiotic recombination. Genes Dev. 2015;29:1256–70. doi: 10.1101/gad.257840.114.
    1. Berglund J, Quilez J, Arndt PF, Webster MT. Germlinemethylation patterns determine the distribution of recombination events in the dog genome. Genome Biol Evol. 2014;7(2):522–30. doi: 10.1093/gbe/evu282.
    1. Yang F, Baumann C, Viveiros MM, De la Fuente R. Histone hyperacetylation during meiosis interferes with large-scale chromatin remodeling, axial chromatid condensation and sister chromatid separation in the mammalian oocyte. Int J Dev Biol. 2012;56:889–99. doi: 10.1387/ijdb.120246rd.
    1. Hann MC, Lau PE, Tempest HG. Meiotic recombination and male infertility: from basic science to clinical reality? Asian J Androl. 2011;13:212–8. doi: 10.1038/aja.2011.1.
    1. Coluzzi E, Colamartino M, Cozzi R, Leone S, Meneghini C, O’Callaghan N, Sgura A. oxidative stress induces persistent telomeric DNA damage responsible for nuclear morphology change in mammalian cells. Plos One. 2014;9(10):e110963. doi: 10.1371/journal.pone.0110963.
    1. Treff NR, Su J, Taylor D, Scott RT., Jr Telomere DNA deficiency is associated with development of human embryonic aneuploidy. Plos Genetics. 2011;7(6):e1002161. doi: 10.1371/journal.pgen.1002161.
    1. D’Angiolella V, Santarpia C, Grieco D. Oxidative stress overrides the spindle checkpoint. Cell Cycle. 2007;6(5):576–9. doi: 10.4161/cc.6.5.3934.
    1. Sivestris E, Cohen M, Menezo Y. Oxidative stress (OS) and DNA methylation errors in reproduction. A place for a support of the one carbon cycle (1-C cycle) before conception. Womens Health Gynecol. 2016;2(4):030.
    1. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. WAO J. 2012;5:9–19.
    1. Banerjee R. Redox outside the box: linking extracellular redox remodeling with intracellular redox metabolism. J Biol Chem. 2012;287(7):4397–402. doi: 10.1074/jbc.R111.287995.
    1. Lushchak VI. Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids. 2012;736837:26.
    1. Belalcázar AD, Ball JG, Frost LM, Valentovic MA, Wilkinson J., IV Transsulfuration is a significant source of sulfur for glutathione production in human mammary epithelial cells. ISRN Biochemistry. 2013;637897:7.
    1. Perna A, Ingrosso D, Lombardi C, Acanfora F, Satta E, Cesare CM, Violetti E, Romano MM, De Santo N. Possible mechanisms of homocysteine toxicity. Kidney Int Suppl. 2003;84:S137–40. doi: 10.1046/j.1523-1755.63.s84.33.x.
    1. Ereño-Orbeaa J, Majtanb T, Oyenartea I, Krausb JP, Martínez-Cruz LA. Structural insight into the molecular mechanism of allosteric activation of human cystathionine β-synthase by S-adenosylmethionine. Proc Natl Acad Sci U S A. 2014;111(37):E3845–52. doi: 10.1073/pnas.1414545111.
    1. Li G, Xie ZZ, Chua JM, Wong PC, Bian J. Hydrogen sulfide protects testicular germ cells against heat-induced injury. Nitric Oxide. 2015;46:165–71. doi: 10.1016/j.niox.2014.10.005.
    1. Liang R, Yu WD, Du JB, Yang LJ, Yang JJ, Xu J, Shang M, Guo JZ. Cystathionine beta synthase participates in murine oocyte maturation mediated by homocysteine. Reprod Toxicol. 2007;24(1):89–96. doi: 10.1016/j.reprotox.2007.04.002.
    1. Banerjee R, Zou CG. Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein. Arch Biochem Biophys. 2005;433(1):144–56. doi: 10.1016/j.abb.2004.08.037.
    1. Janosík M, Kery V, Gaustadnes M, Maclean KN, Kraus JP. Regulation of human cystathionine beta-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry. 2001;40(35):10625–33. doi: 10.1021/bi010711p.
    1. Lewis SEM, Aitken RJ, Conner SJ, De Iuliis G, Evenson DP, Henkel R, Giwercman A, Gharagozloo P. The impact of sperm DNA damage in assisted conception and beyond: recent advances in diagnosis and treatment. Reprod Biomed Online. 2013;27:325–37. doi: 10.1016/j.rbmo.2013.06.014.
    1. Showell MG, Mackenzie-Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2014;12:CD007411.
    1. Showell MG, Brown J, Clarke J, Hart RJ. Antioxidants for female subfertility. Cochrane Database Syst Rev. 2013;8:CD007807.
    1. Lombardo F, Sansone A, Romanelli F, Paoli D, Gandini L, Lenzi A. The role of antioxidant therapy in the treatment of male infertility: an overview. Asian J Androl. 2011;13:690–7. doi: 10.1038/aja.2010.183.
    1. Gharagozloo P, Aitken RJ. The role of sperm oxidative stress in male infertility and the significance of oral antioxidant therapy. Human Reprod. 2011;26(7):1628–40. doi: 10.1093/humrep/der132.
    1. Ménézo YJ, Hazout A, Panteix G, Robert F, Rollet J, Cohen-Bacrie P, Chapuis F, Clément P, Benkhalifa M. Antioxidants to reduce sperm DNA fragmentation: an unexpected adverse effect. Reprod Biomed Online. 2007;14:418–21. doi: 10.1016/S1472-6483(10)60887-5.
    1. Meyer-Ficca ML, Lonchar JD, Ihara M, Meistrich ML, Austin CA, Meyer RG. Poly(ADP-Ribose) polymerases PARP1 and PARP2 modulate topoisomerase II beta (TOP2B) function during chromatin condensation in mouse spermiogenesis. Biol Reprod. 2011;84:900–9. doi: 10.1095/biolreprod.110.090035.
    1. Alano CC, Garnier P, Ying W, Higashi Y, Kauppinen TM, Swanson RA. NAD+ depletion is necessary and sufficient for PARP-1—mediated neuronal death. J Neurosci. 2010;30(8):2967–78. doi: 10.1523/JNEUROSCI.5552-09.2010.
    1. Roberts Stein L, Imai S. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab. 2012;23(9):420–8. doi: 10.1016/j.tem.2012.06.005.
    1. Roohani N, Hurrell R, Kelishadi R, Schulin R. Zinc and its importance for human health: an integrative review. J Res Med Sci. 2013;18(2):144–57.
    1. Wegmuller R, Tay F, Zeder C, Brnic M, Hurrell RF. Zinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide. J Nutr. 2014;144:132–6. doi: 10.3945/jn.113.181487.
    1. Dattilo M, Cornet D, Amar E, Cohen M, Menezo Y. The importance of the one carbon cycle nutritional support in human male fertility: a preliminary clinical report. Reprod Biol Endocrinol. 2014;12:71. doi: 10.1186/1477-7827-12-71.
    1. Amar E, Cornet D, Cohen M, Menezo Y. Treatment for high levels of sperm DNA fragmentation and nuclear de condensation: sequential treatment with a potent antioxidant followed by stimulation of the one-carbon cycle vs one-carbon cycle back-up alone. Austin J Reprod Med Infertil. 2015;2(1):1006.
    1. Cornet D, Amar E, Cohen M, Menezo Y. Clinical evidence for the importance of 1-Carbon Cycle Support in Subfertile Couples. Austin J Reprod Med Infertil. 2015; 2(2).
    1. Lamirande E, Tsai C, Harakat A, Gagnon C. Involvement of reactive oxygen species in human sperm acrosome reaction induced by A23187, lysophosphatidylcholine, and biological fluids ultrafiltrate. J Androl. 1998;19(5):585–94.
    1. Boitrelle F, Pagnier M, Athiel Y, Swierkowski-Blanchard N, Torre A, Alter L, Muratorio C, Vialard F, Albert M, Selva J. A human morphologically normal spermatozoon may have noncondensed chromatin. Andrologia. 2015;47(8):879–86.
    1. van der Put NMJ, Fons Gabreels F, Stevens EMB, Smeitink JAM. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects. Am J Hum Genet. 1998;62:1044–51. doi: 10.1086/301825.
    1. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Redlund M, Stoll C, Alembik Y, Dott B, Czeizel AE, Gelman-Kohan Z, Scarano G, Bianca S, Ettore G, Tenconi R, Bellato S, Scala I, Mutchinick OM, López MA, de Walle H, Hofstra R, Joutchenko L, Kavteladze L, Bermejo E, Martínez-Frías ML, Gallagher M, Erickson JD, Vollset SE, Mastroiacovo P, Andria G, Botto LD. Geographical and ethnic variation of the 677C > T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet. 2003;40:619–25. doi: 10.1136/jmg.40.8.619.
    1. Zappacosta B, Romano L, Persichilli S, Luigi A, Cutrone LA, Graziano M, Vitrani A, Di Castelnuovo A, Giardina B, Musumeci S, Mastroiacovo P. Genotype prevalence and allele frequencies of 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in Italian newborns. Labmedicine. 2009;40(12):732–6.
    1. Liu K, Zhao R, Shen M, Ye J, Li X, Huang Y, Hua L, Wang Z, Li J. Role of genetic mutations in folate-related enzyme genes on male Infertility. Sci Rep. 2015;9(5):15548. doi: 10.1038/srep15548.
    1. Gong M, Dong W, He T, Shi Z, Huang G, Ren R, Huang S, Qiu S, Yuan R. MTHFR 677C > T polymorphism increases the male infertility risk: a meta-analysis involving 26 studies. PLoS One. 2015;10(3):e0121147. doi: 10.1371/journal.pone.0121147.
    1. Shen O, Liu R, Wu W, Yu L, Wang X. Association of the methylenetetrahydrofolate reductase gene A1298C polymorphism with male infertility: a meta-analysis. Ann Hum Genet. 2012;76:25–32. doi: 10.1111/j.1469-1809.2011.00691.x.
    1. Altmäe S, Stavreus-Evers A, Ruiz JR, Laanpere M, Syvänen T, Yngve A, Salumets A, Nilsson TK. Variations in folate pathway genes are associated with unexplained female infertility. Fertil Steril. 2010;94(1):130–7. doi: 10.1016/j.fertnstert.2009.02.025.
    1. Pavlik R, Hecht S, Ochsenkühn R, Noss U, Lohse P, Thaler CJ. Divergent effects of the 677C > T mutation of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene on ovarian responsiveness andanti-Müllerian hormone concentrations. Fertil Steril. 2011;95(7):2257–2262.
    1. Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, Guan D, Hu J, Wang Y, Zhang F, Xu X, Wang X, Xu X, Huo Y. MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults. Nutr J. 2012;11:2. doi: 10.1186/1475-2891-11-2.
    1. Hoffbrand AV, Jackson BF. Correction of the DNA synthesis defect in vitamin B12 deficiency by tetrahydrofolate: evidence in favour of the methyl-folate trap hypothesis as the cause of megaloblastic anaemia in vitamin B12 deficiency. Br J Haematol. 1993;83(4):643–7. doi: 10.1111/j.1365-2141.1993.tb04704.x.
    1. Watkins D, Ru M, Hwang HY, Kim CD, Murray A, Philip NS, Kim W, Legakis H, Wai T, Hilton JF, Ge B, Doré C, Hosack A, Wilson A, Gravel RA, Shane B, Hudson TJ, Rosenblatt DS. Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L. Am J Hum Genet. 2002;71:143–53. doi: 10.1086/341354.
    1. Aşlar D, Hakkı T. Prevalence of MTHFR, MTR and MTRR gene polymorphisms in Turkish patients with nonsyndromic cleft lip and palate. Gene Ther Mol Biol. 2014;16:115–29.
    1. Yang Q-E, Botto LD, Gallagher M, Friedman JM, Sanders CL, Koontz D, Nikolova S, Erickson JD, Steinberg K. Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr. 2008;88:232–46.
    1. Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, Kessler JA, Reed MC, Nijhout HF, George TM, Enterline DS, Gilbert JR, Speer MC, and the NTD Collaborative Group Environ Health Persp. 2006;114(10):1547–52. doi: 10.1289/ehp.9166.
    1. Morin I, Platt R, Weisberg I, Sabbaghian N, Wu Q, Garrow TA, Rozen R. Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Am J Med Genet A. 2003;119A(2):172–6. doi: 10.1002/ajmg.a.20115.
    1. Johnson AR, Craciunescu CN, Guo Z, Teng Y-W, Thresher RJ, Blusztajn J, Zeisel SH. Deletion of murine choline dehydrogenase results in diminished sperm motility. FASEB J. 2010;24(8):2752–61. doi: 10.1096/fj.09-153718.
    1. U.S. National Library of Medicine, Genetics home references: Genes, CBS. . Accessed 22 Jun 2016.
    1. Tsai MY, Bignell M, Schwichtenberg K, Hanson NQ. High prevalence of a mutation in the cystathionine B-synthase gene. Am J Hum Genet. 1996;59:1262–7.
    1. Shih VE, Fringer JM, Mandell R, Kraus JP, Berry GT, Heidenreich RA, Korson MS, Levy HL, Ramesh V. A missense mutation (1278T) in the cystathionine p-synthase gene prevalent in pyridoxine-responsive homocystinuria and associated with mild clinical phenotype. Am J Hum Genet. 1995;57:34–9.
    1. Mayor-Olea A, Callejón G, Palomares AR, Jiménez AJ, Gaitán MJ, Rodríguez A, Ruiz M, Reyes-Engel A. Human genetic selection on the MTHFR 677C > T polymorphism. BMC Medical Genetics. 2008;9:104. doi: 10.1186/1471-2350-9-104.
    1. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004;159:423–43. doi: 10.1093/aje/kwh066.
    1. Robien K, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B, Potter JD, Radic JP. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin Can Res. 2004;10:7592–8. doi: 10.1158/1078-0432.CCR-04-1057.
    1. Meadows DN, Pyzik M, Wu Q, Torre S, Gros P, Vidal SM, Rozen R. Increased resistance to malaria in mice with methylenetetrahydrofolate reductase (Mthfr) deficiency suggests a mechanism for selection of the MTHFR 677C > T (c.665C > T) variant. Hum Mutat. 2014;35(5):594–600. doi: 10.1002/humu.22533.
    1. Terruzzi I, Senesi P, Montesano A, La Torre A, Alberti G, Benedini S, Caumo A, Fermo I, Luzi L. Genetic polymorphisms of the enzymes involved in DNA methylation and synthesis in elite athletes. Physiol Genomics. 2011;43:965–73. doi: 10.1152/physiolgenomics.00040.2010.
    1. Wang C, Riedl KM, Schwartz SJ. A liquid chromatography–tandem mass spectrometric method for quantitative determination of native 5-methyltetrahydrofolate and its polyglutamyl derivatives in raw vegetables. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(29):2949–58. doi: 10.1016/j.jchromb.2010.08.043.
    1. Block G, Jensen CD, Norkus EP, Dalvi TB, Wong LG, McManus JF, Hudes ML. Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study. Nutr J. 2007;6:30. doi: 10.1186/1475-2891-6-30.
    1. Pfeiffer CM, Sternberg MR, Fazili Z, Yetley EA, Lacher DA, Bailey RL, Johnson CL. Unmetabolized folic acid is detected in nearly all serum samples from US children, adolescents, and adults. J Nutr. 2015;145:520–31. doi: 10.3945/jn.114.201210.
    1. Ulrich CM, Potter JD. Folate Supplementation: Too Much of a Good Thing? Cancer Epidemiol Biomarkers Prev. 2006;15(2):189–93. doi: 10.1158/1055-9965.EPI-152CO.
    1. Neuhouser ML, Nijhout HF, Gregory JF III, Reed MC, James SJ, Liu A, Shane B, Ulrich CM. Mathematical modeling predicts the effect offolate deficiency and excess on cancer related biomarkers. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1912–1917.
    1. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER, Polyp Prevention Study Group Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297:2351–9. doi: 10.1001/jama.297.21.2351.
    1. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr. 2006;83:895–4.
    1. Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, Selhub J, McTiernan A, Yasui Y, Oral E, Potter JD, Ulrich CM. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2006;136:189–94.
    1. Sweeney MR, Staines A, Daly L, Traynor A, Daly S, Bailey SW, Alverson PB, Ayling JE, Scott JM. Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification? BMC Public Health. 2009;9:295. doi: 10.1186/1471-2458-9-295.
    1. Kennedy D, Koren NDG. Identifying women who might benefit from higher doses of folic acid in pregnancy. Can Fam Physician. 2012;58(4):394–7.
    1. Opinion of the Scientific Panel on Food Additives Flavourings, processing aids and materials in contact with food on a request from the commission related to calcium l-methylfolate. EFSA J. 2004;135:1–20.
    1. Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food on a request from the Commission on adenosylcobalamin and methylcobalamin as sources for Vitamin B12. EFSA J. 2008; 815: 1-21.
    1. Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr. 2003;133:1302–7.
    1. Ingenbleek Y. The Nutritional Relationship Linking Sulfur to Nitrogen in Living Organisms. J Nutr. 2006;136:1641S–51.
    1. Hoffman JR, Falvo MJ. Protein—which is the best? J Sports Sci Med. 2004;3:118–30.
    1. USDA National Agricultural Library, Food and Nutrition Information Centre. . Accessed 22 Jun 2016.
    1. National Institutes of Health, Office of Dietary Supplements, Dietary Supplements Facts Sheets. . Accessed 22 Jun 2016.
    1. Iniesta MD, Pérez-Conesa D, García-Alonso J, Ros G, Periago MJ. Folate content in tomato (Lycopersicon esculentum). Influence of cultivar, ripeness, year of harvest, and pasteurization and storage temperatures. J Agric Food Chem. 2009;57(11):4739–45. doi: 10.1021/jf900363r.
    1. Hoehn KL, Salmonb AB, Hohnen-Behrensa C, Turnera N, Hoya AJ, Maghzalc GJ, Stockerc R, Van Remmenb H, Kraegena EW, Cooneya GJ, Richardsonb AR, James DE. Insulin resistance is a cellular antioxidant defense mechanism. PNAS. 2009;106(42):17787–92. doi: 10.1073/pnas.0902380106.

Source: PubMed

3
구독하다